(a) The Fatality and Mortality Review Team is created under the Bureau for Public Health. The Fatality and Mortality Review Team is a multidisciplinary team created to oversee and coordinate the examination, review and assessment of: (1) The deaths of all persons in West Virginia who die as a result of unintentional prescription or pharmaceutical […]
(a) The Fatality and Mortality Review Team shall establish the following advisory panels to carry out the purposes of this article, including: (1) An unintentional pharmaceutical drug overdose fatality review panel to examine, analyze, and review deaths resulting from unintentional prescription or pharmaceutical drug overdose;
(a) Notwithstanding any other provision of this code to the contrary, the Fatality and Mortality Review Team and the advisory panels established by the team pursuant to this article may request information and records as necessary to carry out its responsibilities. Records and information that may be requested under this section include: (1) Medical, dental […]
(a) Proceedings, records, and opinions of the Fatality and Mortality Review Team and the advisory panels established by the team pursuant to this article are confidential and are not subject to discovery, subpoena, or introduction into evidence in any civil or criminal proceeding. This section does not limit or restrict the right to discover or […]
(a) The infant and mortality review panel shall annually analyze data to identify themes, underlying risk factors, and gaps in care, to understand factors related to deaths during pregnancy, delivery, and the postpartum period. This analysis is required to follow the Centers for Disease Control and Preventions best practices for maternal mortality review and infant […]
